Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study
NCT04992975 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-03-21
Summary
A longitudinal observational neuroimaging study of individuals with Early Onset Alzheimer's disease during the prodromal phase, and matched control group - Ultrahigh Field MRI study at 7T
Conditions
- Prodromal Alzheimer's Disease
- Mild Cognitive Impairment
Interventions
- OTHER
-
MRI at 7T
MRI at 7T
Sponsors & Collaborators
-
Nottingham University Hospitals NHS Trust
lead OTHER
Principal Investigators
-
Akram Hosseini · Nottingham University Hospitals NHS Trust
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-10
- Primary Completion
- 2025-03-31
- Completion
- 2025-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
NCT00704327 ·Status: TERMINATED
-
Isotopic Imaging for Prodromal Alzheimer's Disease
NCT01231295 ·Status: COMPLETED
-
Study of Iron Accumulation Measured in MRI in Non-pathological Aging
NCT04659824 ·Status: RECRUITING
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
[18F]NIDF PET Imaging in Tau-related Diseases
NCT07306598 ·Status: RECRUITING
-
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
NCT02103894 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
NCT02062099 ·Status: COMPLETED ·Phase: PHASE1
-
Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke
NCT01829386 ·Status: COMPLETED
-
Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.
NCT03863041 ·Status: COMPLETED ·Phase: NA
-
New Imaging Biomarkers Predictive of MA Progression
NCT05939362 ·Status: RECRUITING ·Phase: NA
-
Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease
NCT05003830 ·Status: UNKNOWN
-
Multi-modal Neuroimaging in Alzheimer's Disease
NCT01554202 ·Status: UNKNOWN ·Phase: NA
-
Prospective Memory Imaging
NCT01638884 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
NCT04141150 ·Status: UNKNOWN ·Phase: PHASE2
-
Determinants of Cognitive Impairment After Acute Coronary Syndrome
NCT00982176 ·Status: COMPLETED
-
Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging
NCT01815112 ·Status: TERMINATED ·Phase: NA
-
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
NCT06965816 ·Status: COMPLETED
-
Assess Fibrin in Brains With AD/ADRD
NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects
NCT00951197 ·Status: COMPLETED
-
[18F]APN-1607 PET in Subjects With AD Compared to HC
NCT05542953 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-drug Methods Study in Participants With Alzheimer's Disease
NCT01459016 ·Status: COMPLETED ·Phase: PHASE1
-
Tau Imaging in Young Onset Dementia
NCT02289118 ·Status: COMPLETED
-
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884 ·Status: COMPLETED